Fingerprint
Dive into the research topics of 'Randomized Phase II Trial of High-Dose Melatonin and Radiation Therapy for RPA Class 2 Patients With Brain Metastases (RTOG 0119)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Randomized Phase II Trial of High-Dose Melatonin and Radiation Therapy for RPA Class 2 Patients With Brain Metastases (RTOG 0119)
Lawrence Berk, Brian Berkey, Tyvin Rich, William Hrushesky, David Blask, Michael Gallagher, Mahesh Kudrimoti, Ronald C. McGarry, John Suh, Minesh Mehta
Research output: Contribution to journal › Article › peer-review
55
Scopus
citations